Ypsomed Holding AG (SWX:YPSN)

Market Cap	3.81B -15.6%
Revenue (ttm)	787.55M +27.6%
Net Income	194.00M +160.8%
EPS	14.21 +160.7%
Shares Out	13.65M
PE Ratio	19.67
Forward PE	20.06
Dividend	2.20 (0.79%)
Ex-Dividend Date	Jul 4, 2025

Volume	9,805
Average Volume	20,705
Open	278.50
Previous Close	280.50
Day's Range	275.50 - 280.50
52-Week Range	260.50 - 441.50
Beta	0.76
RSI	44.66
Earnings Date	May 20, 2026

About Ypsomed Holding AG

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insu...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1984
• Employees: 2,000
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: YPSN

Financial Performance

In fiscal year 2025, Ypsomed Holding AG's revenue was 748.87 million, an increase of 36.54% compared to the previous year's 548.46 million. Earnings were 87.50 million, an increase of 11.66%.